Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome
About
Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment.
EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.
Network
EXIMIOUS is part of the European Human Exposome Network and brings together 15 partner organisations from 7 European countries.
FAQ
Don’t know what the exposome is?
Want to know more about exposure-related immune diseases?
Curious to know more about what to expect from this project?
Project facts
EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.
- Concept: introduce a new approach to mapping exposure-induced immune effects by combining exposomics and immunomics in a unique toolbox.
- Budget: 10.8 million Euro
- Duration: 01.01.2020 - 31.12.2024
Latest news
EXIMIOUS shortlisted at KU Leuven Horizon Europe Launch Event
Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome EXIMIOUS project shortlisted at KU Leuven Horizon Europe Launch Event December 18, 2020 As part of a recent KU Leuven initiative, researchers participating in FP7 and H2020 research projects were invited to submit their project description to one or more of the following categories: training
Latest Tweets
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.